|
|
||||||||
Department of Medicine, Division of Cardiovascular Medicine, University of Pennsylvania Medical Center, 3400 Spruce St, 6 Penn Tower, Philadelphia, PA 19104
(Email: alexander.opotowsky@uphs.upenn.edu).
| The first 20% of the full text of this article appears below. |
To the Editor:
We read with interest the article by Karamlou and colleagues [1] on patent foramen ovale/atrial septal defect (PFO/ASD) closure utilization. We previously published a report on trends in percutaneous and surgical PFO/ASD closure using the same database [2]. Their excellent article presents important data on this increasingly common procedure. There are two points we would like to address.
First is the assertion that the development of percutaneous techniques is driving utilization. Percutaneous ASD closure (and, with modifications, PFO closure) has become possible and popular only in the
Related Article
Ann. Thorac. Surg. 2009 88: 1386-1387.
This article has been cited by other articles:
![]() |
T. Karamlou, B. S. Diggs, B. W. McCrindle, R. M. Ungerleider, and K. F. Welke Reply Ann. Thorac. Surg., October 1, 2009; 88(4): 1386 - 1387. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |